Hyperprolactinemia as a side effect of using antipsychotics In Schizophrenic Patients

Hyperprolactinemia as a side effect of using antipsychotics In Schizophrenic Patients

Introductions: Antipsychotics are still the mainstay of schizophrenia management. Antipsychotics are antagonistic to postsynaptic dopamine receptors in the brain. Blockade of dopamine receptors in the tuberoinfundibular pathway by antipsychotics will cause the side effect of hyperprolactinemia. Obje...

Full description

Bibliographic Details
Main Authors:	Syaiful Anwar, Khairina
Format:	Article
Language:	English
Published:	Universitas Airlangga 2023-11-01
Series:	Jurnal Psikiatri Surabaya
Online Access:	https://e-journal.unair.ac.id/JPS/article/view/23359

Similar Items

Antipsychotic-induced Hyperprolactinemia
by: Suheyla Dogan Bulut, et al.
Published: (2015-06-01)

The effect of antipsychotic medication and the associated hyperprolactinemia as a risk factor for periodontal diseases in schizophrenic patients: a cohort retrospective study
by: Rania Shalaby, et al.
Published: (2023-10-01)

Hyperprolactinemia with antipsychotics and the need for magnetic resonance imaging
by: M.D.C. Molina Liétor, et al.
Published: (2022-06-01)

Hormonal alterations due to antipsychotic-related hyperprolactinemia
by: A.L. Montejo, et al.
Published: (2022-06-01)

Treatment of antipsychotic-induced parkinsonism in schizophrenic patients
by: E. E. Vaiman, et al.
Published: (2021-08-01)

Sexual differences in the clinical features of antipsychotic-induced hyperprolactinemia in patients with schizophrenia
by: E. G. Kornetova, et al.
Published: (2019-10-01)

Effect of antipsychotic drugs and orthostatic hypotension on the risk of falling in schizophrenic patients
by: Ferinauli Ferinauli, et al.
Published: (2021-04-01)

Hyperprolactinemia in patients taking antipsychotics: the importance of a shared approach between psychiatry and endocrinology
by: M. Mousinho, et al.
Published: (2023-03-01)

Peony-Glycyrrhiza Decoction for Antipsychotic-Related Hyperprolactinemia in Patients with Schizophrenia: A Randomized Controlled Trial
by: Wang Z, et al.
Published: (2023-04-01)

Treatment of antipsychotic-induced hyperprolactinemia: an umbrella review of systematic reviews and meta-analyses
by: Qitong Jiang, et al.
Published: (2024-03-01)

Hyperprolactinemia during application of second-generation antipsychotics: the principles of prevention, diagnosis and correction
by: L. N. Gorobets, et al.
Published: (2018-07-01)

Is there constitutional and morphological predisposition to akathisia in schizophrenic patients receiving antipsychotic therapy?
by: A. A. Goncharova, et al.
Published: (2020-01-01)

Incidence of Orthostatic Hypotension in Schizophrenic Patients Using Antipsychotics at Sambang Lihum Mental Health Hospital, South Kalimantan
by: Noor Cahaya, et al.
Published: (2021-08-01)

MULTIPLEX ANALYSIS OF PERIPHERAL BIOMARKERS IN SCHIZOPHRENIC PATIENTS WITH LONG-TERM ANTIPSYCHOTIC THERAPY
by: A. S. Boiko, et al.
Published: (2019-01-01)

Efficacy and safety of Tianmeng Oral Liquid in the treatment of hyperprolactinemia caused by antipsychotics in female patients with schizophrenia： a Meta-analysis
by: Lan Xianjun, et al.
Published: (2023-02-01)

Description of clinical portraits of patients with hyperprolactinemia
by: Larisa K. Dzeranova, et al.
Published: (2018-10-01)

Hyperprolactinemia in patients with chronic kidney disease
by: І.О. Dudar, et al.
Published: (2021-01-01)

Relationship of PLR, NLR and LMR with Metabolic Syndrome in Schizophrenic Patients on Antipsychotics: A Longitudinal Case-control Study
by: Prashant Maravi, et al.
Published: (2023-02-01)

Editorial: Insights in hyperprolactinemia
by: Maria M. Pineyro, et al.
Published: (2024-01-01)

Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
by: Elena E. Vaiman, et al.
Published: (2021-07-01)

Hyperprolactinemia in Subclinical Hypothyroid Patients at BPKIHS, Dharan
by: Rajendra Tamrakar, et al.
Published: (2023-07-01)

Clinical guidelines ‘Hyperprolactinemia’ (draft)
by: I. I. Dedov, et al.
Published: (2023-07-01)

Neuroleptic hyperprolactinemia medicamentous correction
by: L. N. Gorobets, et al.
Published: (2018-07-01)

Is hyperprolactinemia the main cause of infertility?
by: Mikaily J, et al.
Published: (1999-06-01)

Hematological Side Effects of Atypical Antipsychotic Drugs
by: Serap Erdogan
Published: (2009-10-01)

A delusion of pregnancy in man with hyperprolactinemia
by: A. Aissa, et al.
Published: (2021-04-01)

Comparative Efficacy of First and Second Generation long-acting injectable antipsychotic upon schizophrenic patients: a systematic review and network metaanalysis.
by: R. Medrano, et al.
Published: (2023-03-01)

Mutant prolactin receptor and familial hyperprolactinemia.
by: Newey, P, et al.
Published: (2014)

Mutant prolactin receptor and familial hyperprolactinemia
by: Newey, P, et al.
Published: (2013)

Hyperprolactinemia in Adults with Prader-Willi Syndrome
by: Anna Sjöström, et al.
Published: (2021-08-01)

Antipsychotic drug effects in a model of schizophrenic attentional disorder: a randomized controlled trial of the effects of haloperidol on latent inhibition in healthy people.
by: Williams, J, et al.
Published: (1996)

Effect of Hyperprolactinemia on Bone Metabolism: Focusing on Osteopenia/Osteoporosis
by: Soo Jin Yun, et al.
Published: (2024-01-01)

Sex differences in antipsychotic efficacy and side effects in psychosis
by: G. Erzin
Published: (2023-03-01)

Metaphor Comprehension in Schizophrenic Patients
by: Ileana Rossetti, et al.
Published: (2018-05-01)

Depressive symptoms in schizophrenic patients
by: Gozdzik-Zelazny A, et al.
Published: (2011-12-01)

Macroprolactinemia among hyperprolactinemia patients in Hospital Universiti Sains Malaysia
by: Che Soh @ Yusof, Noor Azlin Azraini
Published: (2015)

The importance of routine screening for macroprolactin in symptomatic patients with idiopathic hyperprolactinemia
by: Lucio Vilar, et al.
Published: (2018-04-01)

New approaches to pharmacogenetics of drug-induced hyperprolactinemia in patients with schizophrenia
by: S. A. Ivanova
Published: (2019-12-01)

Correlation Between Family Cohesion and Recurrence in Schizophrenics at the dr. Soetomo Hospital Psychiatric Clinic
by: Derryl Rasad Texaga, et al.
Published: (2022-05-01)

Obesity associated with neuroleptic drugs, value of hyperprolactinemia
Published: (2013-06-01)